Skip to main content

Advertisement

Log in

Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Introduction

An integrated PET/MRI scanner has been used in selected cases of pediatric brain tumor patients to obtain additional metabolic information about lesions for preoperative biopsy planning and navigation.

Patients and methods

Four patients, age 9–16 years, received PET/MRI scans employing [11C]methionine positron emission tomography (PET) and contrast-enhanced 3D-MR sequences for neuronavigation. PET and MR sequences have been matched for neurosurgical guidance. An infrared camera-based neuronavigation system was employed with co-registered MR and PET images fused to hybrid images for preoperative planning, stereotactic biopsy planning, and/or intraoperative guidance.

Results

All patients showed hot spots of increased amino acid transport in PET and contrast-enhancing lesions in MRI. In three of the four patients, PET hot spots were congruent with contrast-enhancing areas in MRI. In two patients, frame-based stereotactic biopsies were taken from thalamo-mesencephalic lesions. One patient underwent second-look surgery for the suspicion of recurrent malignant glioma of the posterior fossa. One incidental frontal mass lesion was subtotally resected. No complications occurred. Hybrid imaging was helpful during the procedures to obtain representative histopathologic specimens and for surgical guidance during resection. Co-registered images did match with intraoperative landmarks, tumor borders, and histopathologic specimens.

Conclusion

The integrated PET/MRI scanner offers co-registered multimodal, high-resolution data for neuronavigation with reduced radiation exposure compared to PET/CT scans. One examination session provides all necessary data for neuronavigation and preoperative planning, avoiding additional anesthesia in the small patients. Hybrid multimodality imaging may improve safety and yield additional information when obtaining representative histopathologic specimens of brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bailey DL, Barthel H, Beyer T, Boellaard R, Gückel B, Hellwig D, Herzog H, Pichler BJ, Quick HH, Sabri O, Scheffler K, Schlemmer HP, Schwenzer NF, Wehrl HF (2012) Summary report of the first international workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany. Mol Imaging Biol 15(4):361–371

    Article  Google Scholar 

  2. Biermann M, Schwarzlmüller T, Fasmer KE, Reitan BC, Johnsen B, Rosendahl K (2013) Is there a role for PET-CT and SPECT-CT in pediatric oncology? Acta Radiol 54(9):1037–1045. doi:10.1258/ar.2012.120616, Epub 2013 Apr 30. Review

    Article  PubMed  Google Scholar 

  3. Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, Werner P, Jochimsen T, Barthel H, Bierbach U, Till H, Sabri O, Kluge R (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43(7):860–875. doi:10.1007/s00247-012-2570-4, Epub 2013 Jan 11

    Article  PubMed Central  PubMed  Google Scholar 

  4. Imani F, Boada FE, Lieberman FS, Davis DK, Deeb EL, Mountz JM (2012) Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging 22(2):184–190

    Article  PubMed Central  PubMed  Google Scholar 

  5. Jadvar H, Colletti PM (2014) Competitive advantage of PET/MRI. Eur J Radiol 83(1):84–94

    Article  PubMed  Google Scholar 

  6. Mertens K, Acou M, Van Hauwe J, De Ruyck I, Van den Broecke C, Kalala JP, D’Asseler Y, Goethals I (2013) Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study. Clin Nucl Med 38(7):495–500. doi:10.1097/RLU.0b013e318292a753

    Article  PubMed  Google Scholar 

  7. Pichler BJ, Kolb A, Nägele T, Schlemmer HP (2010) PET/MRI: paving the way for next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336

    Article  PubMed  Google Scholar 

  8. Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions. J Neurosurg Pediatr 5(5):479–485

    Article  PubMed  Google Scholar 

  9. Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumor. J Neurosurg Pediatr 5(5):486–499

    Article  PubMed  Google Scholar 

  10. Sattler B, Jochimsen T, Barthel H, Sommerfeld K, Stumpp P, Hoffmann KT, Gutberlet M, Villringer A, Kahn T, Sabri O (2013) Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting. MAGMA 26(1):159–171

    Article  PubMed  Google Scholar 

  11. Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ (2010) Combined PET/MR: one step further in multimodality imaging. Trends Mol Med 16:508–515

    Article  PubMed  Google Scholar 

  12. Thorsen F, Fite B, Mahakian LM, Seo JW, Qin S, Harrison V, Johnson S, Ingham E, Caskey C, Sundstrøm T, Meade TJ, Harter PN, Skaftnesmo KO, Ferrara KW (2013) Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release 172(3):812–822. doi:10.1016/j.jconrel.2013.10.019, Epub 2013 Oct 29

    Article  CAS  PubMed  Google Scholar 

  13. Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):56–68

    Article  Google Scholar 

  14. Wehrl HF, Schwab J, Hasenbach K, Reischl G, Tabatabai G, Quintanilla-Martinez L, Jiru F, Chughtai K, Kiss A, Cay F, Bukala D, Heeren RM, Pichler BJ, Sauter AW (2013) Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography. Cancer Res 73(5):1470–1480. doi:10.1158/0008-5472.CAN-12-2532, Epub 2013 Jan 23

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthias Preuss.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preuss, M., Werner, P., Barthel, H. et al. Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors. Childs Nerv Syst 30, 1399–1403 (2014). https://doi.org/10.1007/s00381-014-2412-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-014-2412-9

Keywords

Navigation